EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Wearable Irregular Heart Rhythm Detection Recurrences and Electrocardiographic Atrial Fibrillation Confirmation: The Fitbit Heart Study

Steven A Lubitz iD, Michael V McConnell iD, Caitlin Selvaggi, Aparna Krishnamoorthy iD, Steven J Atlas iD, David D McManus iD, Sherry Pagoto iD, Daniel E Singer iD, Alexandros Pantelopoulos, Andrea S Foulkes iD, Anthony Z Faranesh iD

Circulation: Arrhythmia and Electrophysiology · 2025-07 · 18 (7)

DOI: 10.1161/circep.124.013565 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2025-07. Verfasst von Steven A Lubitz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Arrhythmia Service and Cardiovascular Research Center, Boston, MA (S.A.L.). Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Rate, Wearable Electronic Devices, Photoplethysmography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Wrist-worn wearables can detect irregular heart rhythms using photoplethysmography, but ECGs are required to confirm atrial fibrillation (AF). We sought to determine the frequency of a recurrent irregular heart rhythm detection (IHRD; ≥30 minutes of an irregular rhythm), estimate the potential diagnostic yield of different electrocardiographic monitoring strategies for confirming AF, and identify predictors of recurrent IHRDs. METHODS: The Fitbit Heart Study enrolled wrist-worn photoplethysmography device users without diagnosed AF. Of 455 699 participants, 1057 who wore and returned a 1-week ECG patch monitor after receiving an IHRD were analyzed. Baseline clinical data, device-derived metrics, IHRDs during follow-up, and electrocardiographic patch data were used for analysis. RESULTS: A total of 570 (53.9%) participants were aged 40 to 64 years, 422 (39.9%) were aged ≥65 years, and 510 (48.2%) were women. Median follow-up after ECG patch initiation was 80 days (interquartile range, 45–122 days). The frequency of another IHRD was 57.2% (95% CI, 53.1%–60.9%) at 3 months. After an initial IHRD, the estimated diagnostic yield for AF with a 10-second ECG was 7.6% (95% CI, 6.2%–9.0%), twice-daily 30-second ECGs over 1 week 19.0% (95% CI, 16.7%–21.2%), 24-hour monitor 17.4% (95% CI, 15.5%–19.3%), 1-week monitor 32.2% (95% CI, 29.4%–35.0%), 2-week monitor 46.8% (95% CI, 42.7%–50.8%), and 4-week monitor 60.8% (95% CI, 56.5%–65.1%). The risk of a recurrent IHRD was greater with older age ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart RateWearable Electronic DevicesPhotoplethysmographyElectrocardiography, AmbulatoryElectrocardiographyHumansFemaleMaleMiddle AgedAgedAdultRecurrencePredictive Value of TestsTime FactorsEquipment Design

Stichwörter der Autor:innen

atrial fibrillationhumanssleepvascular diseases

Autor:innen und Institutionen

  • Cardiac Arrhythmia Service and Cardiovascular Research Center, Boston, MA (S.A.L.).
  • Harvard Medical School, Boston, MA (S.A.L., S.J.A., D.E.S., A.S.F.).
  • Fitbit LLC (Google LLC), San Francisco, CA (M.V.M.C., A.P., A.Z.F.).
  • Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA (M.V.M.C.).
  • Biostatistics Center, Boston, MA (C.S., A.K., A.S.F.).
  • Division of General Internal Medicine, Massachusetts General Hospital, Boston (S.J.A., D.E.S.).

ORCID-Profile: Steven A Lubitz, Michael V McConnell, Aparna Krishnamoorthy, Steven J Atlas, David D McManus, Sherry Pagoto, Daniel E Singer, Andrea S Foulkes, Anthony Z Faranesh

Förderung

  • American Heart Association-American Stroke Association
  • NHLBI NIH HHS

Zitieren

APA

Lubitz, S. A., McConnell, M. V., Selvaggi, C., Krishnamoorthy, A., Atlas, S. J., McManus, D. D., Pagoto, S., Singer, D. E., Pantelopoulos, A., Foulkes, A. S., & Faranesh, A. Z. (2025). Wearable Irregular Heart Rhythm Detection Recurrences and Electrocardiographic Atrial Fibrillation Confirmation: The Fitbit Heart Study. Circulation: Arrhythmia and Electrophysiology, 18(7). https://doi.org/10.1161/circep.124.013565

Vancouver

Lubitz SA, McConnell MV, Selvaggi C, Krishnamoorthy A, Atlas SJ, McManus DD, et al. Wearable Irregular Heart Rhythm Detection Recurrences and Electrocardiographic Atrial Fibrillation Confirmation: The Fitbit Heart Study. Circulation: Arrhythmia and Electrophysiology. 2025;18(7). doi:10.1161/circep.124.013565

BibTeX
@article{Lubitz2025,
  author = {Lubitz, Steven A and McConnell, Michael V and Selvaggi, Caitlin and Krishnamoorthy, Aparna and Atlas, Steven J and McManus, David D and Pagoto, Sherry and Singer, Daniel E and Pantelopoulos, Alexandros and Foulkes, Andrea S and Faranesh, Anthony Z},
  title = {Wearable Irregular Heart Rhythm Detection Recurrences and Electrocardiographic Atrial Fibrillation Confirmation: The Fitbit Heart Study},
  journal = {Circulation: Arrhythmia and Electrophysiology},
  year = {2025},
  volume = {18},
  number = {7},
  doi = {10.1161/circep.124.013565}
}
Kostenlos starten →